GAO Finds Higher Pathology Service Referrals By Physicians Who Self-Refer
This article was originally published in The Gray Sheet
Executive Summary
The Government Accountability Office recommends that CMS remove financial incentives for specialists to self-refer pathology work to in-house laboratories or facilities in which they have a financial interest.
You may also be interested in...
Pathologist Group Focuses On SGR, Self-Referrals, EHRs On Capitol Hill
The College of American Pathologists is optimistic about achieving permanent reform to the Medicare physician payment system based on Senate Finance Chair Ron Wyden’s laser focus on the issue. Jonathan Myles, who chairs CAP’s economic affairs committee, discussed the group’s legislative priorities.
Self-Referral Drives Extra Prostate Biopsy Activity, Study Suggests
A Medicare claims analysis compared biopsy trends in men referred for biopsy analysis by urologists who use a pathology lab to which they have a financial association, and those who see urologists that order biopsies at unassociated labs.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.